Analysen zu Novartis AG
| 22.11.24 | Novartis Hold | Deutsche Bank AG | |
| 22.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Underweight | Barclays Capital | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.11.24 | Novartis Buy | UBS AG | |
| 20.11.24 | Novartis Hold | Deutsche Bank AG | |
| 14.11.24 | Novartis Buy | UBS AG | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Outperform | Bernstein Research | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.10.24 | Novartis Hold | Deutsche Bank AG | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Kaufen | DZ BANK | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 10.07.24 | Novartis Buy | Deutsche Bank AG | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Deutsche Bank AG | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | Novartis Underweight | Barclays Capital | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.06.24 | Novartis Buy | Deutsche Bank AG | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.05.24 | Novartis Buy | UBS AG |
Aktuelle Aktienanalysen
| 11.12.25 | National Grid Outperform | Bernstein Research | |
| 11.12.25 | RWE Outperform | Bernstein Research | |
| 11.12.25 | E.ON Market-Perform | Bernstein Research | |
| 11.12.25 | Diageo Overweight | Barclays Capital | |
| 11.12.25 | AB InBev Overweight | Barclays Capital | |
| 11.12.25 | Richemont Overweight | Barclays Capital | |
| 11.12.25 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 11.12.25 | Unilever Buy | Deutsche Bank AG | |
| 11.12.25 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 11.12.25 | Carl Zeiss Meditec Overweight | Barclays Capital | |
| 11.12.25 | LVMH Moet Hennessy Louis Vuitton Equal Weight | Barclays Capital | |
| 11.12.25 | Oracle Overweight | Barclays Capital | |
| 11.12.25 | Deutsche Börse Overweight | Barclays Capital | |
| 11.12.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 11.12.25 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 11.12.25 | Deutsche Telekom Outperform | Bernstein Research | |
| 11.12.25 | RWE Overweight | Barclays Capital | |
| 11.12.25 | Enel Overweight | Barclays Capital | |
| 11.12.25 | PATRIZIA Buy | Warburg Research | |
| 11.12.25 | Jungheinrich Buy | Warburg Research | |
| 11.12.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 11.12.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 11.12.25 | Schneider Electric Outperform | RBC Capital Markets | |
| 11.12.25 | Fraport Hold | Warburg Research | |
| 11.12.25 | ASML NV Buy | UBS AG | |
| 11.12.25 | Delivery Hero Buy | UBS AG | |
| 11.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | E.ON Neutral | UBS AG | |
| 11.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 11.12.25 | Roche Buy | UBS AG | |
| 11.12.25 | Münchener Rückversicherungs-Gesellschaft Neutral | UBS AG | |
| 11.12.25 | Douglas Neutral | UBS AG | |
| 11.12.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 11.12.25 | Enel Buy | Jefferies & Company Inc. | |
| 11.12.25 | TUI Market-Perform | Bernstein Research | |
| 11.12.25 | Oracle Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | SCHOTT Pharma Sector Perform | RBC Capital Markets | |
| 11.12.25 | Fraport Hold | Jefferies & Company Inc. | |
| 11.12.25 | Rheinmetall Outperform | Bernstein Research | |
| 11.12.25 | Münchener Rückversicherungs-Gesellschaft Hold | Jefferies & Company Inc. | |
| 11.12.25 | Alzchem Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.12.25 | Scout24 Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.12.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.12.25 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Kering Underweight | JP Morgan Chase & Co. | |
| 11.12.25 | Roche Underperform | Jefferies & Company Inc. | |
| 11.12.25 | LVMH Moet Hennessy Louis Vuitton Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Ferrari Overweight | JP Morgan Chase & Co. |